March 3, 2009 – Acura Pharmaceuticals, Inc. and King Pharmaceuticals, Inc. today announced that Acura’s New Drug Application for Acurox (oxycodone HCl/niacin) Tablets was accepted for filing by the US FDA with a Priority review classification. Acurox is an immediate release opioid analgesic, has a proposed indication for relief of moderate-to-severe pain and is designed to deter common methods of misuse and abuse.
The details can be read here.
No comments:
Post a Comment